Ken Inchausti is a Managing Director in the Strategic Communications segment with nearly 30 years of experience and is based in New York and Philadelphia. He brings nearly 30 years of experience delivering corporate and brand communications in the life sciences, hospital and patient advocacy sectors. As an in-house leader and spokesperson, Ken has launched reputation and corporate brand campaigns, led global product communications programs and spearheaded issues and crisis management efforts with global CEOs and U.S. executive teams. As a seasoned communicator, Ken is adept at providing counsel across disciplines, including executive management, marketing, investor relations, research and development, legal and compliance, market access and pricing, public affairs, medical affairs and human resources.
Prior to joining FTI Consulting, Ken served as the Head of Investor Relations & Communications at a biotechnology firm, Ocugen. Additionally, for a decade, Ken was a senior communications leader at Novo Nordisk, Inc., leading a team that drove reputational strategies which engaged stakeholders and led to positive growth. Ken successfully shaped Novo Nordisk’s response to insulin affordability criticisms, led corporate media relations efforts for drug approvals, created the U.S. corporate social media ecosystem, renewed corporate branding and storytelling and launched Cities Changing Diabetes, a public/private partnership in Houston, Texas.
Ken’s life sciences background includes serving in global and U.S. communications leadership roles at GSK. He brings extensive industry insight to the table due to his work in neurosciences, vaccines and oncology. Ken regularly played a critical role in media relations, research and development communications, public affairs, regulatory milestone and launch communications, post-merger employee integration and issues/crisis management.
Further experience includes managing communications efforts at Premier, Inc., a hospital group purchasing organization, consulting healthcare clients at Fleishman Hillard and working at the American Diabetes Association. Additionally, Ken holds a Bachelor’s of Arts in Speech Communications from Old Dominion University.